PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors. Gabbay joins the board of the Swiss company after spending time in leadership roles with the American Diabetes Association (ADA). Peterson spent more than two decades as a medtech CEO and more recently served as executive […]
Personnel
Know Labs appoints new chief science, technology officers
Know Labs (NYSE:KNW) announced today that it appointed a new chief science officer (CSO) and interim chief technology officer (CTO). The company picked Dominic Klyve to serve as CSO, while John Cronin takes up the interim CTO role. Seattle-based Know Labs develops non-invasive diagnostic technology, including a wearable continuous glucose monitor (CGM). The company unveiled […]
Glooko announces CEO transition with $100M financing
Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO. Russ Johannesson said on LinkedIn that he stepped down from the CEO post at Glooko. He held the corner office for six-and-a-half years as Alvarez now takes over. Alvarez brings more than two decades of […]
Fresenius Kabi USA appoints new president
Fresenius Kabi announced that Arunesh Verma joined as the president of Fresenius Kabi USA and as a member of its global executive leadership team. As a member of the executive leadership team, Verma reports to CEO Pierluigi Antonelli. He holds responsibility for the commercial operations of Fresenius Kabi in the U.S., succeeding John Ducker. Ducker […]
Tandem Diabetes Care has a new COO
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it appointed Jean-Claude “JC” Kyrillos as its new EVP and COO. Kyrillos’ appointment goes into effect on June 21, 2024. He joins Tandem with more than 20 years of experience in global executive leadership across medtech, digital health and healthcare management. Most recently, Kyrillos served in operating company […]
Medtronic Diabetes has a new medical affairs director
Medtronic (NYSE:MDT) announced today that Dr. Goran Petrovski joined its Diabetes operating unit as medical affairs director. His role includes shaping the clinical evidence strategy and product design for Medtronic’s diabetes technology. The company also expects him to strengthen its presence in Central Europe, the Middle East and Africa. Petrovski brings more than 20 years […]
Stevanato Group brings former CEO back to corner office
Stevanato Group (NYSE:STVN) announced today that its board of directors appointed Franco Stevanato as its new CEO. Stevanato, currently a board director and the company’s executive chair, succeeds Franco Moro in the corner office. Moro’s employment agreement continues through June 30, 2024, after which he will remain on the company’s board. This marks Stevanato’s second […]
Vaccine patch maker Vaxess raises $12M, names new CEO
Shelf-stable vaccine patch maker Vaxess Technologies announced today that it raised $12 million and appointed Rachel Sha as its new CEO. This round brings the company’s total funding to more than $90 million after it raised $9 million last September as well. Investors included RA Capital Management, Engine Ventures, GHIC and Mission Bio Capital. Cambridge, […]
Kindeva Drug Delivery has a new COO
Kindeva Drug Delivery announced today that it appointed Denis Johnson as its new chief operating officer (COO). Johnson’s responsibilities include leading global operations for Kindeva’s manufacturing and R&D facilities across the U.S. and UK. The company expects him to facilitate the expansion and opening of the company’s new aseptic injectable fill-finish site in Bridgeton, Missouri. […]
Insulet picks new CFO following McMillan’s move to 3M spinoff
Insulet (Nasdaq:PODD) announced today that it appointed Ana Maria Chadwick as its new EVP, CFO and treasurer. Chadwick’s appointment — which goes into effect on April 22, 2024 — follows an extensive search process conducted by Insulet. That search spanned nearly six months after former CFO Wayde McMillan left for 3M’s Solventum healthcare spinoff in […]
